93 related articles for article (PubMed ID: 16546861)
1. Concurrent chemoradiation therapy with low-dose CDDP and UFT for glottic carcinomas: evaluation using the sixth edition of the UICC TNM staging system.
Murakami R; Nishimura R; Baba Y; Yumoto E; Oya N; Yamashita Y
Acta Oncol; 2006; 45(2):162-7. PubMed ID: 16546861
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors of glottic carcinomas treated with radiation therapy: value of the adjacent sign on radiological examinations in the sixth edition of the UICC TNM staging system.
Murakami R; Nishimura R; Baba Y; Furusawa M; Ogata N; Yumoto E; Yamashita Y
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):471-5. PubMed ID: 15667969
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of concurrent radiation therapy with UFT or TS-1 for T2N0 glottic cancer in Japan.
Niibe Y; Nakayama M; Matsubayashi T; Takahashi H; Kitano M; Okamoto M; Hayakawa K
Anticancer Res; 2007; 27(5B):3497-500. PubMed ID: 17972507
[TBL] [Abstract][Full Text] [Related]
4. [Survival of glottic carcinoma patients treated with definitive radiation therapy: value of the Sixth edition of the UICC TNM staging system].
Murakami R; Baba Y; Nishimura R; Morishita S; Tsuchigame T; Yamashita Y; Yumoto E
Nihon Igaku Hoshasen Gakkai Zasshi; 2004 Nov; 64(8):570-4. PubMed ID: 15651363
[TBL] [Abstract][Full Text] [Related]
5. Retrospective analysis: concurrent chemoradiotherapy and adjuvant chemotherapy for T2N0 glottic squamous cell carcinoma.
Nonoshita T; Shioyama Y; Kunitake N; Nakamura K; Nomoto S; Ohga S; Toriya Y; Ono M; Honda H
Fukuoka Igaku Zasshi; 2009 Jan; 100(1):26-31. PubMed ID: 19378773
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of concurrent chemoradiotherapy for T1 and T2 laryngeal squamous cell carcinoma regarding organ preservation.
Nishimura G; Tsukuda M; Mikami Y; Matsuda H; Horiuchi C; Taguchi T; Takahashi M; Kawakami M; Watanabe M; Niho T; Abo H; Yamomoto S
Anticancer Res; 2009 Feb; 29(2):661-6. PubMed ID: 19331217
[TBL] [Abstract][Full Text] [Related]
7. Concurrent chemoradiotherapy with carboplatin and uracil-ftegafur in patients with stage two (T2 N0 M0) squamous cell carcinoma of the glottic larynx.
Taguchi T; Tsukuda M; Mikami Y; Horiuchi C; Ishitoya JI; Katori H
J Laryngol Otol; 2006 Jun; 120(6):478-81. PubMed ID: 16563197
[TBL] [Abstract][Full Text] [Related]
8. [Concurrent chemoradiotherapy with S-1 for T2N0 glottic carcinoma].
Ikeda Y; Tsukuda M; Tanigaki Y; Yabuki K; Mitake D; Ishitoya J
Gan To Kagaku Ryoho; 2008 May; 35(5):789-92. PubMed ID: 18487914
[TBL] [Abstract][Full Text] [Related]
9. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
[TBL] [Abstract][Full Text] [Related]
10. Concurrent hyperfractionated radiotherapy and carboplatin with transoral debulking microsurgery for T2N0 glottic cancer.
Ohguri T; Imada H; Nakano K; Yahara K; Udaka T; Suzuki H; Korogi Y
Head Neck; 2008 Aug; 30(8):1027-34. PubMed ID: 18302271
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent conformal (3D-CRT) chemoradiation.
Moreno-Jiménez M; Aristu J; López-Picazo JM; Ramos LI; Gúrpide A; Gómez-Iturriaga A; Valero J; Martínez-Monge R
Radiother Oncol; 2008 Sep; 88(3):342-50. PubMed ID: 18558448
[TBL] [Abstract][Full Text] [Related]
12. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR
Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998
[TBL] [Abstract][Full Text] [Related]
13. A phase I study of concurrent chemoradiotherapy with S-1 for T2N0 glottic carcinoma.
Tsuji H; Kiba T; Nagata M; Inoue T; Yukawa H; Yamashita T; Shimode Y; Murata H; Nagata K; Tomoda K
Oncology; 2006; 71(5-6):369-73. PubMed ID: 17851262
[TBL] [Abstract][Full Text] [Related]
14. Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma.
Nomiya T; Nemoto K; Wada H; Takai Y; Yamada S
Laryngoscope; 2008 Aug; 118(8):1417-21. PubMed ID: 18528306
[TBL] [Abstract][Full Text] [Related]
15. Combined chemoradiotherapy for early glottic cancer in clinical practice in Japan: analysis of 10 institutions.
Itoh Y; Hirasawa N; Naganawa S; Ishihara S; Suzuki K; Koyama K; Murao T; Asano A; Nomoto Y; Horikawa Y; Sasaoka M; Obata Y
Anticancer Res; 2010 Dec; 30(12):5181-4. PubMed ID: 21187509
[TBL] [Abstract][Full Text] [Related]
16. Restaging of differentiated thyroid carcinoma by the sixth edition AJCC/UICC TNM staging system: stage migration and predictability.
Lang B; Lo CY; Chan WF; Lam KY; Wan KY
Ann Surg Oncol; 2007 May; 14(5):1551-9. PubMed ID: 17318278
[TBL] [Abstract][Full Text] [Related]
17. Effect of body mass index on chemoradiation outcomes in head and neck cancer.
McRackan TR; Watkins JM; Herrin AE; Garrett-Mayer EM; Sharma AK; Day TA; Gillespie MB
Laryngoscope; 2008 Jul; 118(7):1180-5. PubMed ID: 18475213
[TBL] [Abstract][Full Text] [Related]
18. Importance of anterior commissure in recurrence of early glottic cancer after laser endoscopic resection.
Chone CT; Yonehara E; Martins JE; Altemani A; Crespo AN
Arch Otolaryngol Head Neck Surg; 2007 Sep; 133(9):882-7. PubMed ID: 17875854
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
Finnegan V; Parsons JT; Greene BD; Sharma V
Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy concurrent with S-1 and radiotherapy alone for T2N0 glottic carcinoma: a retrospective comparative study.
Higashino M; Kawata R; Lee K; Nishikawa S; Ichihara S; Uesugi Y
Auris Nasus Larynx; 2014 Aug; 41(4):364-8. PubMed ID: 24656970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
